US Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Sell
47,471
-3,892
-8% -$1.28M 0.02% 359
2025
Q4
$18M Sell
51,363
-6,624
-11% -$2.24M 0.02% 339
2025
Q3
$18.7M Sell
57,987
-1,451
-2% -$451K 0.02% 334
2025
Q2
$23.1M Sell
59,438
-401
-0.7% -$161K 0.03% 298
2025
Q1
$26M Sell
59,839
-1,524
-2% -$612K 0.03% 277
2024
Q4
$22.6M Buy
61,363
+511
+0.8% +$214K 0.03% 296
2024
Q3
$31.6M Sell
60,852
-622
-1% -$332K 0.04% 255
2024
Q2
$33.3M Buy
61,474
+1,543
+3% +$816K 0.05% 230
2024
Q1
$31.1M Sell
59,931
-530
-0.9% -$264K 0.04% 242
2023
Q4
$28.5M Buy
60,461
+2,396
+4% +$1.11M 0.04% 245
2023
Q3
$25M Sell
58,065
-7,913
-12% -$3.59M 0.04% 260
2023
Q2
$29.3M Sell
65,978
-5,165
-7% -$2.38M 0.05% 242
2023
Q1
$32.7M Sell
71,143
-2,001
-3% -$952K 0.06% 218
2022
Q4
$37.5M Buy
73,144
+33,345
+84% +$16.9M 0.07% 199
2022
Q3
$18.1M Sell
39,799
-589
-1% -$282K 0.04% 266
2022
Q2
$19.5M Sell
40,388
-426
-1% -$211K 0.04% 270
2022
Q1
$20M Buy
40,814
+2,233
+6% +$1.02M 0.03% 297
2021
Q4
$17.9M Buy
38,581
+2,134
+6% +$898K 0.03% 322
2021
Q3
$13.6M Sell
36,447
-3,831
-10% -$1.46M 0.03% 344
2021
Q2
$15.4M Sell
40,278
-744
-2% -$284K 0.03% 333
2021
Q1
$14.7M Sell
41,022
-2,666
-6% -$857K 0.03% 328
2020
Q4
$14M Buy
43,688
+1,441
+3% +$442K 0.03% 330
2020
Q3
$11.3M Sell
42,247
-4,548
-10% -$1.22M 0.03% 340
2020
Q2
$12.3M Sell
46,795
-4,097
-8% -$1.09M 0.03% 322
2020
Q1
$11.6M Buy
50,892
+1,934
+4% +$527K 0.04% 305
2019
Q4
$14.8M Sell
48,958
-308
-0.6% -$84.8K 0.04% 303
2019
Q3
$11.8M Sell
49,266
-9,189
-16% -$2.52M 0.03% 330
2019
Q2
$16.5M Buy
58,455
+2,477
+4% +$677K 0.05% 284
2019
Q1
$16.1M Sell
55,978
-4,900
-8% -$1.42M 0.05% 282
2018
Q4
$16M Buy
60,878
+577
+1% +$159K 0.05% 265
2018
Q3
$16.5M Sell
60,301
-1,072
-2% -$278K 0.05% 273
2018
Q2
$14.6M Buy
61,373
+713
+1% +$165K 0.04% 286
2018
Q1
$13.3M Sell
60,660
-2,951
-5% -$693K 0.04% 299
2017
Q4
$14.3M Sell
63,611
-129
-0.2% -$27.5K 0.04% 287
2017
Q3
$12.1M Buy
63,740
+11,555
+22% +$2.2M 0.04% 305
2017
Q2
$9.82M Sell
52,185
-3,421
-6% -$615K 0.03% 348
2017
Q1
$9.2M Buy
55,606
+2,176
+4% +$346K 0.03% 353
2016
Q4
$7.68M Buy
53,430
+3,543
+7% +$474K 0.03% 381
2016
Q3
$6.25M Sell
49,887
-2,254
-4% -$291K 0.02% 413
2016
Q2
$6.85M Sell
52,141
-1,431
-3% -$196K 0.03% 391
2016
Q1
$7.45M Buy
53,572
+458
+0.9% +$61.2K 0.03% 373
2015
Q4
$7.41M Buy
53,114
+1,770
+3% +$244K 0.03% 372
2015
Q3
$7.19M Sell
51,344
-13,975
-21% -$2.1M 0.03% 386
2015
Q2
$10.7M Buy
65,319
+12,478
+24% +$1.99M 0.04% 322
2015
Q1
$8.16M Buy
52,841
+559
+1% +$79.6K 0.03% 370
2014
Q4
$6.57M Sell
52,282
-1,999
-4% -$247K 0.03% 398
2014
Q3
$6.49M Sell
54,281
-1,877
-3% -$215K 0.03% 394
2014
Q2
$6.04M Sell
56,158
-9,816
-15% -$1.01M 0.02% 410
2014
Q1
$6.57M Sell
65,974
-4,841
-7% -$438K 0.03% 386
2013
Q4
$6.54M Buy
70,815
+5,142
+8% +$457K 0.03% 369
2013
Q3
$5.49M Sell
65,673
-5,549
-8% -$476K 0.02% 386
2013
Q2
$5.83M Buy
+71,222
New +$5.33M 0.03% 372

Other funds holding ELV